Inclusion Criteria:~1. Capable of giving and capacity to give informed consent~2. An individual who can act as
a reliable study partner with regular contact (combination of face to face visits / telephone contact
acceptable) who has sufficient subject interaction to provide meaningful input into rating scales and, if
necessary, supervise or perform the injections, as judged by the investigator~3. Diagnosis of Probable
Alzheimer's disease according to Dubois criteria (Dubois, Feldman et al. 2007) or National Institute of
Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association
(NINCDS-ADRDA) criteria~4. Age from 50 years~5. Mini-Mental State Examination (MMSE) score of ≥20 and
CDR-Global score of 0.5 or 1~6. Rosen Modified Hachinski Ischemic score ≤4~7. On stable medication for 2 months
before the screening visit; on or off cholinesterase inhibitors~8. Fluency in English and evidence of adequate
premorbid intellectual functioning~9. Likely to be able to participate in all scheduled evaluations and
complete all required tests~
